COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 192 filers reported holding MYRIAD GENETICS INC in Q3 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$878,078
-58.9%
54,743
-40.6%
0.01%
-58.8%
Q2 2023$2,136,895
+7.2%
92,187
+7.4%
0.02%0.0%
Q1 2023$1,993,157
+158338.6%
85,801
-1.1%
0.02%
+54.5%
Q4 2022$1,258
-99.9%
86,725
+18.0%
0.01%
-21.4%
Q3 2022$1,402,000
+5.3%
73,468
+0.3%
0.01%0.0%
Q2 2022$1,331,000
-23.3%
73,241
+6.4%
0.01%
-17.6%
Q1 2022$1,735,000
+4.1%
68,843
+14.1%
0.02%0.0%
Q4 2021$1,666,000
-12.8%
60,355
+2.0%
0.02%
-22.7%
Q3 2021$1,911,000
+5.7%
59,182
+0.1%
0.02%
+10.0%
Q2 2021$1,808,000
+2.4%
59,131
+1.9%
0.02%
-9.1%
Q1 2021$1,766,000
+53.3%
58,002
-0.4%
0.02%
+37.5%
Q4 2020$1,152,000
+52.4%
58,262
+0.5%
0.02%
+6.7%
Q3 2020$756,000
+77.5%
57,972
+54.5%
0.02%
+87.5%
Q2 2020$426,000
-20.5%
37,529
+0.3%
0.01%
-33.3%
Q1 2020$536,000
-22.0%
37,427
+48.4%
0.01%0.0%
Q4 2019$687,000
-4.2%
25,219
+0.7%
0.01%
-7.7%
Q3 2019$717,000
+2.7%
25,054
-0.3%
0.01%
+8.3%
Q2 2019$698,000
-16.4%
25,130
-0.1%
0.01%
-20.0%
Q1 2019$835,000
+12.1%
25,148
-1.9%
0.02%0.0%
Q4 2018$745,000
-4.4%
25,636
+51.4%
0.02%
+36.4%
Q3 2018$779,000
+40.9%
16,931
+14.5%
0.01%
+57.1%
Q2 2018$553,00014,7870.01%
Other shareholders
MYRIAD GENETICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Camber Capital Management LP 2,750,000$75,900,0002.61%
PFM Health Sciences, LP 2,025,681$55,909,0001.90%
Tieton Capital Management, LLC 118,456$3,269,0001.83%
Altium Capital Management LP 190,000$5,244,0001.45%
DISCIPLINED GROWTH INVESTORS INC /MN 1,846,490$50,963,0001.03%
EARNEST PARTNERS LLC 6,316,365$174,332,0001.01%
Glenview Capital Management 1,679,747$46,361,0000.99%
Zebra Capital Management LLC 14,209$392,0000.63%
AIMZ Investment Advisors, LLC 44,185$1,220,0000.48%
Phocas Financial Corp. 132,101$3,646,0000.46%
View complete list of MYRIAD GENETICS INC shareholders